0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Immune Repertoire Sequencing - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-2Q6518
Home | Market Reports | Science
Global Immune Repertoire Sequencing Market Insights Forecast to 2028
BUY CHAPTERS

Immune Repertoire Sequencing - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-2Q6518
Report
December 2023
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immune Repertoire Sequencing - Market Size

The global Immune Repertoire Sequencing market size is expected to reach US$ 128.8 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029.

Immune Repertoire Sequencing -  Market

Immune Repertoire Sequencing - Market

Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
The market is mainly driven by the significant applications of Immune Repertoire Sequencing in various end use industries. The expanding demands from the Bioinformatics, Hematology, Immunology and Others, are propelling Immune Repertoire Sequencing market. Pyro-Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dye-Terminating Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immune Repertoire Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Immune Repertoire Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Repertoire Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Immune Repertoire Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Repertoire Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Repertoire Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Repertoire Sequencing covered in this report include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc.
The global Immune Repertoire Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific

Scope of Immune Repertoire Sequencing - Market Report

Report Metric Details
Report Name Immune Repertoire Sequencing - Market
Forecasted market size in 2029 US$ 128.8 million
CAGR 3.2%
Forecasted years 2023 - 2029
Global Immune Repertoire Sequencing market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Repertoire Sequencing market, Segment by Type:
  • Pyro-Sequencing
  • Dye-Terminating Sequencing
  • Others
Global Immune Repertoire Sequencing market, by Application
  • Bioinformatics
  • Hematology
  • Immunology
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Immune Repertoire Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Immune Repertoire Sequencing - Market size in 2029?

Ans: The Immune Repertoire Sequencing - Market size in 2029 will be US$ 128.8 million.

What are the Application segmentation covered in the Immune Repertoire Sequencing - Market report?

Ans: The Applications covered in the Immune Repertoire Sequencing - Market report are Bioinformatics, Hematology, Immunology, Others

What are the Type segmentation covered in the Immune Repertoire Sequencing - Market report?

Ans: The Types covered in the Immune Repertoire Sequencing - Market report are Pyro-Sequencing, Dye-Terminating Sequencing, Others

1 Market Overview of Immune Repertoire Sequencing
1.1 Immune Repertoire Sequencing Market Overview
1.1.1 Immune Repertoire Sequencing Product Scope
1.1.2 Immune Repertoire Sequencing Market Status and Outlook
1.2 Global Immune Repertoire Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immune Repertoire Sequencing Market Size by Region (2018-2029)
1.4 Global Immune Repertoire Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Immune Repertoire Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immune Repertoire Sequencing Market Size (2018-2029)
1.6.1 North America Immune Repertoire Sequencing Market Size (2018-2029)
1.6.2 Europe Immune Repertoire Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Immune Repertoire Sequencing Market Size (2018-2029)
1.6.4 Latin America Immune Repertoire Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Immune Repertoire Sequencing Market Size (2018-2029)
2 Immune Repertoire Sequencing Market by Type
2.1 Introduction
2.1.1 Pyro-Sequencing
2.1.2 Dye-Terminating Sequencing
2.1.3 Others
2.2 Global Immune Repertoire Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
3 Immune Repertoire Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Bioinformatics
3.1.2 Hematology
3.1.3 Immunology
3.1.4 Others
3.2 Global Immune Repertoire Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
4 Immune Repertoire Sequencing Competition Analysis by Players
4.1 Global Immune Repertoire Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Repertoire Sequencing as of 2022)
4.3 Date of Key Players Enter into Immune Repertoire Sequencing Market
4.4 Global Top Players Immune Repertoire Sequencing Headquarters and Area Served
4.5 Key Players Immune Repertoire Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Immune Repertoire Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adaptive Biotechnologies & Amgen
5.1.1 Adaptive Biotechnologies & Amgen Profile
5.1.2 Adaptive Biotechnologies & Amgen Main Business
5.1.3 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Products, Services and Solutions
5.1.4 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Adaptive Biotechnologies & Amgen Recent Developments
5.2 BGI
5.2.1 BGI Profile
5.2.2 BGI Main Business
5.2.3 BGI Immune Repertoire Sequencing Products, Services and Solutions
5.2.4 BGI Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 BGI Recent Developments
5.3 Alacris Theranostics
5.3.1 Alacris Theranostics Profile
5.3.2 Alacris Theranostics Main Business
5.3.3 Alacris Theranostics Immune Repertoire Sequencing Products, Services and Solutions
5.3.4 Alacris Theranostics Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 CD Genomics Recent Developments
5.4 CD Genomics
5.4.1 CD Genomics Profile
5.4.2 CD Genomics Main Business
5.4.3 CD Genomics Immune Repertoire Sequencing Products, Services and Solutions
5.4.4 CD Genomics Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 CD Genomics Recent Developments
5.5 AptaIT
5.5.1 AptaIT Profile
5.5.2 AptaIT Main Business
5.5.3 AptaIT Immune Repertoire Sequencing Products, Services and Solutions
5.5.4 AptaIT Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 AptaIT Recent Developments
5.6 ArcherDX
5.6.1 ArcherDX Profile
5.6.2 ArcherDX Main Business
5.6.3 ArcherDX Immune Repertoire Sequencing Products, Services and Solutions
5.6.4 ArcherDX Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 ArcherDX Recent Developments
5.7 Roche Holding
5.7.1 Roche Holding Profile
5.7.2 Roche Holding Main Business
5.7.3 Roche Holding Immune Repertoire Sequencing Products, Services and Solutions
5.7.4 Roche Holding Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Holding Recent Developments
5.8 ThermoFisher Scietific
5.8.1 ThermoFisher Scietific Profile
5.8.2 ThermoFisher Scietific Main Business
5.8.3 ThermoFisher Scietific Immune Repertoire Sequencing Products, Services and Solutions
5.8.4 ThermoFisher Scietific Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 ThermoFisher Scietific Recent Developments
6 North America
6.1 North America Immune Repertoire Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immune Repertoire Sequencing Market Dynamics
11.1 Immune Repertoire Sequencing Industry Trends
11.2 Immune Repertoire Sequencing Market Drivers
11.3 Immune Repertoire Sequencing Market Challenges
11.4 Immune Repertoire Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Immune Repertoire Sequencing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Immune Repertoire Sequencing Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Immune Repertoire Sequencing Market Size Share by Region (2018-2023)
    Table 4. Global Immune Repertoire Sequencing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Immune Repertoire Sequencing Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Immune Repertoire Sequencing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Immune Repertoire Sequencing Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Immune Repertoire Sequencing Revenue Market Share by Type (2018-2023)
    Table 9. Global Immune Repertoire Sequencing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Immune Repertoire Sequencing Revenue Market Share by Type (2024-2029)
    Table 11. North America Immune Repertoire Sequencing Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Immune Repertoire Sequencing Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Immune Repertoire Sequencing Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Immune Repertoire Sequencing Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Immune Repertoire Sequencing Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Immune Repertoire Sequencing Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Immune Repertoire Sequencing Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Immune Repertoire Sequencing Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Immune Repertoire Sequencing Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Immune Repertoire Sequencing Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Immune Repertoire Sequencing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Immune Repertoire Sequencing Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Immune Repertoire Sequencing Revenue Market Share by Application (2018-2023)
    Table 24. Global Immune Repertoire Sequencing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Immune Repertoire Sequencing Revenue Market Share by Application (2024-2029)
    Table 26. North America Immune Repertoire Sequencing Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Immune Repertoire Sequencing Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Immune Repertoire Sequencing Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Immune Repertoire Sequencing Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Immune Repertoire Sequencing Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Immune Repertoire Sequencing Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Immune Repertoire Sequencing Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Immune Repertoire Sequencing Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Immune Repertoire Sequencing Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Immune Repertoire Sequencing Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Immune Repertoire Sequencing Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Immune Repertoire Sequencing Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Repertoire Sequencing as of 2022)
    Table 39. Date of Key Players Enter into Immune Repertoire Sequencing Market
    Table 40. Global Immune Repertoire Sequencing Key Players Headquarters and Area Served
    Table 41. Immune Repertoire Sequencing Product Solution and Service
    Table 42. Global Immune Repertoire Sequencing Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Adaptive Biotechnologies & Amgen Basic Information List
    Table 45. Adaptive Biotechnologies & Amgen Description and Business Overview
    Table 46. Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Immune Repertoire Sequencing Business of Adaptive Biotechnologies & Amgen (2018-2023)
    Table 48. Adaptive Biotechnologies & Amgen Recent Developments
    Table 49. BGI Basic Information List
    Table 50. BGI Description and Business Overview
    Table 51. BGI Immune Repertoire Sequencing Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Immune Repertoire Sequencing Business of BGI (2018-2023)
    Table 53. BGI Recent Developments
    Table 54. Alacris Theranostics Basic Information List
    Table 55. Alacris Theranostics Description and Business Overview
    Table 56. Alacris Theranostics Immune Repertoire Sequencing Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Immune Repertoire Sequencing Business of Alacris Theranostics (2018-2023)
    Table 58. Alacris Theranostics Recent Developments
    Table 59. CD Genomics Basic Information List
    Table 60. CD Genomics Description and Business Overview
    Table 61. CD Genomics Immune Repertoire Sequencing Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Immune Repertoire Sequencing Business of CD Genomics (2018-2023)
    Table 63. CD Genomics Recent Developments
    Table 64. AptaIT Basic Information List
    Table 65. AptaIT Description and Business Overview
    Table 66. AptaIT Immune Repertoire Sequencing Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Immune Repertoire Sequencing Business of AptaIT (2018-2023)
    Table 68. AptaIT Recent Developments
    Table 69. ArcherDX Basic Information List
    Table 70. ArcherDX Description and Business Overview
    Table 71. ArcherDX Immune Repertoire Sequencing Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Immune Repertoire Sequencing Business of ArcherDX (2018-2023)
    Table 73. ArcherDX Recent Developments
    Table 74. Roche Holding Basic Information List
    Table 75. Roche Holding Description and Business Overview
    Table 76. Roche Holding Immune Repertoire Sequencing Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Immune Repertoire Sequencing Business of Roche Holding (2018-2023)
    Table 78. Roche Holding Recent Developments
    Table 79. ThermoFisher Scietific Basic Information List
    Table 80. ThermoFisher Scietific Description and Business Overview
    Table 81. ThermoFisher Scietific Immune Repertoire Sequencing Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Immune Repertoire Sequencing Business of ThermoFisher Scietific (2018-2023)
    Table 83. ThermoFisher Scietific Recent Developments
    Table 84. North America Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
    Table 85. North America Immune Repertoire Sequencing Market Size by Country (2024-2029) & (US$ Million)
    Table 86. Europe Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
    Table 87. Europe Immune Repertoire Sequencing Market Size by Country (2024-2029) & (US$ Million)
    Table 88. Asia-Pacific Immune Repertoire Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 89. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2018-2023) & (US$ Million)
    Table 90. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2018-2023)
    Table 92. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2024-2029)
    Table 93. Latin America Immune Repertoire Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 94. Latin America Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Immune Repertoire Sequencing Market Size by Country (2024-2029) & (US$ Million)
    Table 96. Middle East & Africa Immune Repertoire Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 97. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
    Table 98. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2024-2029) & (US$ Million)
    Table 99. Immune Repertoire Sequencing Market Trends
    Table 100. Immune Repertoire Sequencing Market Drivers
    Table 101. Immune Repertoire Sequencing Market Challenges
    Table 102. Immune Repertoire Sequencing Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immune Repertoire Sequencing Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Immune Repertoire Sequencing Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Immune Repertoire Sequencing Market Share by Regions: 2022 VS 2029
    Figure 4. Global Immune Repertoire Sequencing Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Immune Repertoire Sequencing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Immune Repertoire Sequencing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Immune Repertoire Sequencing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Immune Repertoire Sequencing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Immune Repertoire Sequencing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Pyro-Sequencing
    Figure 11. Global Pyro-Sequencing Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Dye-Terminating Sequencing
    Figure 13. Global Dye-Terminating Sequencing Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Others
    Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Immune Repertoire Sequencing Market Size Share by Type: 2022 & 2029
    Figure 17. North America Immune Repertoire Sequencing Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Immune Repertoire Sequencing Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Immune Repertoire Sequencing Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Immune Repertoire Sequencing Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Immune Repertoire Sequencing Revenue Market Share by Type (2018-2029)
    Figure 22. Bioinformatics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Hematology Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Immunology Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Global Immune Repertoire Sequencing Market Size Share by Application: 2022 & 2029
    Figure 27. North America Immune Repertoire Sequencing Revenue Market Share by Application (2018-2029)
    Figure 28. Europe Immune Repertoire Sequencing Revenue Market Share by Application (2018-2029)
    Figure 29. Asia-Pacific Immune Repertoire Sequencing Revenue Market Share by Application (2018-2029)
    Figure 30. Latin America Immune Repertoire Sequencing Revenue Market Share by Application (2018-2029)
    Figure 31. Middle East and Africa Immune Repertoire Sequencing Revenue Market Share by Application (2018-2029)
    Figure 32. Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 33. Global Top 5 and Top 10 Players Immune Repertoire Sequencing Market Share in 2022
    Figure 34. North America Immune Repertoire Sequencing Market Share by Country (2018-2029)
    Figure 35. U.S. Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 36. Canada Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 37. Germany Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 38. France Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 39. U.K. Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 40. Italy Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 41. Russia Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 42. Nordic Countries Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 43. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2018-2029)
    Figure 44. China Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 45. Japan Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 46. South Korea Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 47. Southeast Asia Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 48. India Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 49. Australia Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 50. Latin America Immune Repertoire Sequencing Market Share by Country (2018-2029)
    Figure 51. Mexico Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 52. Brazil Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Immune Repertoire Sequencing Market Share by Country (2018-2029)
    Figure 54. Turkey Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 56. UAE Immune Repertoire Sequencing Market Size (2018-2029) & (US$ Million)
    Figure 57. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS